SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...
THOUSAND OAKS, Calif., and RADNOR, Penn., – New data from multiple studies evaluating the use of ENBREL® (etanercept), the only fully human TNF receptor, in patients with long-standing disease, as ...
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it. By Rebecca Robbins With a sticker price ...
WASHINGTON, June 16 (Reuters) - U.S. Food and Drug Administration reviewers are concerned about life-threatening complications in children taking Amgen Inc's drug Enbrel for psoriasis and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback